Last edition
News about "Exeltis"
Lupin, Exeltis bag reimbursement approval for NaMuscla in Spain
NaMuscla is Europe's first and only licensed product for this indication, and it will be commercialised in Spain by Lupin's partner Exeltis
Exeltis | 11/01/2023 | By Sudeep Soparkar | 585
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members